ASP Isotopes (NASDAQ:ASPI) COO Robert Ainscow Sells 8,438 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 8,438 shares of the business’s stock in a transaction on Friday, March 6th. The stock was sold at an average price of $5.44, for a total transaction of $45,902.72. Following the completion of the sale, the chief operating officer directly owned 1,537,817 shares of the company’s stock, valued at $8,365,724.48. This represents a 0.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

ASP Isotopes Stock Up 4.5%

ASPI opened at $5.80 on Tuesday. The company has a market cap of $642.87 million, a P/E ratio of -4.46 and a beta of 3.55. The business’s 50-day moving average price is $6.22 and its 200-day moving average price is $7.65. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04. ASP Isotopes Inc. has a 12 month low of $3.71 and a 12 month high of $14.49.

Hedge Funds Weigh In On ASP Isotopes

A number of hedge funds have recently modified their holdings of the company. ProShare Advisors LLC raised its stake in shares of ASP Isotopes by 12.4% during the third quarter. ProShare Advisors LLC now owns 13,101 shares of the company’s stock valued at $126,000 after acquiring an additional 1,448 shares during the last quarter. Ameritas Investment Partners Inc. grew its stake in shares of ASP Isotopes by 41.2% in the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock worth $40,000 after purchasing an additional 1,600 shares during the last quarter. Mercer Global Advisors Inc. ADV increased its holdings in ASP Isotopes by 8.3% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock valued at $203,000 after purchasing an additional 1,622 shares during the period. The Manufacturers Life Insurance Company raised its position in ASP Isotopes by 9.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock valued at $153,000 after purchasing an additional 1,878 shares during the last quarter. Finally, Legal & General Group Plc raised its position in ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock valued at $81,000 after purchasing an additional 1,953 shares during the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Cantor Fitzgerald initiated coverage on ASP Isotopes in a research report on Thursday, December 4th. They set an “overweight” rating and a $13.00 price target on the stock. Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 price objective on shares of ASP Isotopes in a research report on Monday, November 24th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, ASP Isotopes has a consensus rating of “Hold” and an average target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.